BioMarin Pharmaceutical | Capital Ordinaire



Ordinary Share Capital Changement Date
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Bayer EUR 982.42M 1.53B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
Incyte USD 194.12M 193.93M 2025-06
Insmed USD 211.11M 209.29M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
PTC Therapeutics USD 79.38M 79.3M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.25B 52.53M 2025-03
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
United Therapeutics USD 45.22M 44.42M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


BioMarin Pharmaceutical Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.